Acumen Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
&-
So good morning, everyone. I hope everyone has had a good conference so far. My name is Chris Tippett, Iâm an associate here on the healthcare investment banking team at JPMorgan. Today, it is my pleasure to introduce Acumen Pharmaceuticals. And without further ado, Iâd like to turn things over to the Chief Executive Officer and President, Dan OâConnell.
Thanks, Chris. Good morning, everyone. Itâs a pleasure to be here today, and we appreciate the invitation to present. And thanks to everyone here in the room, great to see some familiar faces, and for everyone on the webcast for taking the time to learn more about Acumen Pharmaceuticals.
Iâm Dan OâConnell, Iâm the President and CEO, as Chris indicated, and Iâm pleased to provide a bit of an overview of the company and some of the more recent data for our ACU193 program. I think youâre going to find, as we see the data, itâs very encouraging and bodes
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
